Short-term surgical outcomes following neoadjuvant immunotherapy in mismatch repair-deficient colorectal cancer: initial experience from a tertiary referral center
Surgical resection of MMR-D CRC following neoadjuvant immunotherapy is safe and associated with low morbidity. Neoadjuvant immunotherapy in MMR-D CRC facilitates high rates of major pathological response.
Authors
- Ayman Ahmed (ORCID: https://orcid.org/0000-0001-5387-1756)
- Ammar Aleter
- Amjad Parvaiz (ORCID: https://orcid.org/0000-0002-4655-1006)
- Mohamed Kurer
- Ali Toffaha
- Ejaz Latif
- Tausief Fatima (ORCID: https://orcid.org/0000-0002-9098-567X)
- Mahmood Al‐Dhaheri (ORCID: https://orcid.org/0000-0001-8195-0486)
- Mohamed H. Abunada
Institutions
- Services Institute of Medical Sciences (PK)
- Hamad Medical Corporation (QA)
Publication Details
- Journal
- Annals of Coloproctology
- Published
- 2025-08-28
- DOI
- https://doi.org/10.3393/ac.2025.00381.0054
- Primary Topic
- Genetic factors in colorectal cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00